Shire Pharmaceuticals is categorized under Wholesale Pharmaceutical Products in Wayne, PA and active since 2004.
Shire Pharmaceuticals was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 5411100 by the NAICS.
If you are seeking more information, feel free to contact Matt Emmens at the company’s single location by writing to 725 Chesterbrook Boulevard, Wayne, Pennsylvania PA 19087 or by phoning (484) 595-8903. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Shire Pharmaceuticals |
| Contact Person: | Matt Emmens |
| Address: | 725 Chesterbrook Boulevard, Wayne, Pennsylvania 19087 |
| Phone Number: | (484) 595-8903 |
| Website Address: | lialda.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 5411100 |
| Share This Business: |
Shire Pharmaceuticals was started in 2004 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 5411100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Matt Emmens for inquiries that concern Shire Pharmaceuticals by calling the company number (484) 595-8903, as your correspondence is most welcome. Additionally, the physical location of the single location of Shire Pharmaceuticals can be found at the coordinates 40.068945,-75.460602 as well as the street address 725 Chesterbrook Boulevard in Wayne, Pennsylvania 19087.
For its online presence, you may visit Shire Pharmaceuticals’s website at lialda.com and engage with its social media outlets through on Twitter and on Facebook.